KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EBITDA (2017 - 2025)

Historic EBITDA for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $167.0 million.

  • Elanco Animal Health's EBITDA rose 14925.37% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 10529.27%. This contributed to the annual value of -$1.5 billion for FY2024, which is 5153.55% up from last year.
  • Elanco Animal Health's EBITDA amounted to $167.0 million in Q3 2025, which was up 14925.37% from $221.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's EBITDA registered a high of $249.0 million during Q1 2025, and its lowest value of -$1.6 billion during Q3 2023.
  • For the 5-year period, Elanco Animal Health's EBITDA averaged around -$457.3 million, with its median value being -$516.0 million (2022).
  • Per our database at Business Quant, Elanco Animal Health's EBITDA crashed by 20697.67% in 2023 and then soared by 14950.3% in 2025.
  • Over the past 5 years, Elanco Animal Health's EBITDA (Quarter) stood at -$635.0 million in 2021, then grew by 15.43% to -$537.0 million in 2022, then decreased by 19.74% to -$643.0 million in 2023, then rose by 14.15% to -$552.0 million in 2024, then surged by 130.25% to $167.0 million in 2025.
  • Its EBITDA stands at $167.0 million for Q3 2025, versus $221.0 million for Q2 2025 and $249.0 million for Q1 2025.